Form 144: Estee Lauder insider to sell 3,723 shares ($339K)
Rhea-AI Filing Summary
The filing reports a proposed sale of common stock of The Estée Lauder Companies, Inc. An individual exercised stock options and intends to sell 3,723 shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $339,065.15. The securities were acquired by stock option exercise and payment was in cash on 08/22/2025. The filing lists total shares outstanding as 359,889,444, and notes no other sales in the past three months. The filer affirms they have no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small officer/director sale following option exercise; immaterial to capitalization.
The notice documents a routine sale of 3,723 common shares acquired via stock option exercise and earmarked for sale through a broker on the NYSE at an aggregate value of $339,065.15. Given the stated outstanding share count of 359,889,444, this transaction represents a very small portion of total equity and is presented as a standard Rule 144 notice with no prior sales reported in the last three months.
TL;DR: Compliance-focused disclosure consistent with insider sale reporting requirements.
The filing fulfills Rule 144 disclosure requirements by providing acquisition details, payment method, broker information, and an explicit attestation about material non-public information. The transaction stems from a stock option exercise and is disclosed as required; there is no indication in the form of material governance issues.